The document discusses enhancing pharmaceutical compliance through various aspects like product development, R&D, and quality assurance. It raises the question of whether digitization can address the challenges posed by numerous compliance documents across departments. Additionally, it mentions Datamatics' consulting services related to enterprise content management and FDA compliance.
Related topics: